Selected research
Market Structure
Global Paracetamol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Paracetamol market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Paracetamol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Paracetamol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Paracetamol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Paracetamol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Paracetamol include Atabay, Farmson, Granules India, Mallinckrodt, Seqens, Sri Krishna Pharma, Anhui BBCA Likang, Anhui Fubore and Anqiu Lu'an, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Paracetamol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Paracetamol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Paracetamol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Paracetamol market size, projected growth trends, production technologies, key applications, and end-use industries.
Paracetamol Segment by Company
Atabay
Farmson
Granules India
Mallinckrodt
Seqens
Sri Krishna Pharma
Anhui BBCA Likang
Anhui Fubore
Anqiu Lu'an
Hebei Jiheng Pharmaceutical
Zhejiang Kangle
Paracetamol Segment by Type
Paracetamol Powder
Paracetamol Granule
Paracetamol Segment by Application
Granule Drug
Tablet Drug
Suspension Drug
Others
Paracetamol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paracetamol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paracetamol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paracetamol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Paracetamol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paracetamol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Paracetamol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Paracetamol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Paracetamol Powder
- Paracetamol Granule
Applications
- Granule Drug
- Tablet Drug
- Suspension Drug
- Others
Companies covered
- Atabay
- Farmson
- Granules India
- Mallinckrodt
- Seqens
- Sri Krishna Pharma
- Anhui BBCA Likang
- Anhui Fubore
- Anqiu Lu'an
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Paracetamol Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Paracetamol Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Paracetamol Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Paracetamol Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Paracetamol Market Dynamics
- 2.1 Paracetamol Industry Trends
- 2.2 Paracetamol Industry Drivers
- 2.3 Paracetamol Industry Opportunities and Challenges
- 2.4 Paracetamol Industry Restraints
3 Paracetamol Market by Manufacturers
- 3.1 Global Paracetamol Revenue by Manufacturers (2021-2026)
- 3.2 Global Paracetamol Sales by Manufacturers (2021-2026)
- 3.3 Global Paracetamol Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Paracetamol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Paracetamol Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Paracetamol Manufacturers, Product Type & Application
- 3.7 Global Paracetamol Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Paracetamol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Paracetamol Players Market Share by Revenue in 2025
- 3.8.3 2025 Paracetamol Tier 1, Tier 2, and Tier 3
4 Paracetamol Market by Type
- 4.1 Paracetamol Type Introduction
- 4.1.1 Paracetamol Powder
- 4.1.2 Paracetamol Granule
- 4.2 Global Paracetamol Sales by Type
- 4.2.1 Global Paracetamol Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Paracetamol Sales by Type (2021-2032)
- 4.2.3 Global Paracetamol Sales Market Share by Type (2021-2032)
- 4.3 Global Paracetamol Revenue by Type
- 4.3.1 Global Paracetamol Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Paracetamol Revenue by Type (2021-2032)
- 4.3.3 Global Paracetamol Revenue Market Share by Type (2021-2032)
5 Paracetamol Market by Application
- 5.1 Paracetamol Application Introduction
- 5.1.1 Granule Drug
- 5.1.2 Tablet Drug
- 5.1.3 Suspension Drug
- 5.1.4 Others
- 5.2 Global Paracetamol Sales by Application
- 5.2.1 Global Paracetamol Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Paracetamol Sales by Application (2021-2032)
- 5.2.3 Global Paracetamol Sales Market Share by Application (2021-2032)
- 5.3 Global Paracetamol Revenue by Application
- 5.3.1 Global Paracetamol Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Paracetamol Revenue by Application (2021-2032)
- 5.3.3 Global Paracetamol Revenue Market Share by Application (2021-2032)
6 Global Paracetamol Sales by Region
- 6.1 Global Paracetamol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Paracetamol Sales by Region (2021-2032)
- 6.2.1 Global Paracetamol Sales by Region (2021-2026)
- 6.2.2 Global Paracetamol Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Paracetamol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Paracetamol Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Paracetamol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Paracetamol Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Paracetamol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Paracetamol Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Paracetamol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Paracetamol Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Paracetamol Revenue by Region
- 7.1 Global Paracetamol Revenue by Region
- 7.1.1 Global Paracetamol Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Paracetamol Revenue by Region (2021-2026)
- 7.1.3 Global Paracetamol Revenue by Region (2027-2032)
- 7.1.4 Global Paracetamol Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Paracetamol Revenue (2021-2032)
- 7.2.2 North America Paracetamol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Paracetamol Revenue (2021-2032)
- 7.3.2 Europe Paracetamol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Paracetamol Revenue (2021-2032)
- 7.4.2 Asia-Pacific Paracetamol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Paracetamol Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Paracetamol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Atabay
- 8.1.1 Atabay Company Information
- 8.1.2 Atabay Business Overview
- 8.1.3 Atabay Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Atabay Paracetamol Product Portfolio
- 8.1.5 Atabay Recent Developments
- 8.2 Farmson
- 8.2.1 Farmson Company Information
- 8.2.2 Farmson Business Overview
- 8.2.3 Farmson Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Farmson Paracetamol Product Portfolio
- 8.2.5 Farmson Recent Developments
- 8.3 Granules India
- 8.3.1 Granules India Company Information
- 8.3.2 Granules India Business Overview
- 8.3.3 Granules India Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Granules India Paracetamol Product Portfolio
- 8.3.5 Granules India Recent Developments
- 8.4 Mallinckrodt
- 8.4.1 Mallinckrodt Company Information
- 8.4.2 Mallinckrodt Business Overview
- 8.4.3 Mallinckrodt Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mallinckrodt Paracetamol Product Portfolio
- 8.4.5 Mallinckrodt Recent Developments
- 8.5 Seqens
- 8.5.1 Seqens Company Information
- 8.5.2 Seqens Business Overview
- 8.5.3 Seqens Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Seqens Paracetamol Product Portfolio
- 8.5.5 Seqens Recent Developments
- 8.6 Sri Krishna Pharma
- 8.6.1 Sri Krishna Pharma Company Information
- 8.6.2 Sri Krishna Pharma Business Overview
- 8.6.3 Sri Krishna Pharma Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sri Krishna Pharma Paracetamol Product Portfolio
- 8.6.5 Sri Krishna Pharma Recent Developments
- 8.7 Anhui BBCA Likang
- 8.7.1 Anhui BBCA Likang Company Information
- 8.7.2 Anhui BBCA Likang Business Overview
- 8.7.3 Anhui BBCA Likang Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Anhui BBCA Likang Paracetamol Product Portfolio
- 8.7.5 Anhui BBCA Likang Recent Developments
- 8.8 Anhui Fubore
- 8.8.1 Anhui Fubore Company Information
- 8.8.2 Anhui Fubore Business Overview
- 8.8.3 Anhui Fubore Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Anhui Fubore Paracetamol Product Portfolio
- 8.8.5 Anhui Fubore Recent Developments
- 8.9 Anqiu Lu'an
- 8.9.1 Anqiu Lu'an Company Information
- 8.9.2 Anqiu Lu'an Business Overview
- 8.9.3 Anqiu Lu'an Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Anqiu Lu'an Paracetamol Product Portfolio
- 8.9.5 Anqiu Lu'an Recent Developments
- 8.10 Hebei Jiheng Pharmaceutical
- 8.10.1 Hebei Jiheng Pharmaceutical Company Information
- 8.10.2 Hebei Jiheng Pharmaceutical Business Overview
- 8.10.3 Hebei Jiheng Pharmaceutical Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hebei Jiheng Pharmaceutical Paracetamol Product Portfolio
- 8.10.5 Hebei Jiheng Pharmaceutical Recent Developments
- 8.11 Zhejiang Kangle
- 8.11.1 Zhejiang Kangle Company Information
- 8.11.2 Zhejiang Kangle Business Overview
- 8.11.3 Zhejiang Kangle Paracetamol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Zhejiang Kangle Paracetamol Product Portfolio
- 8.11.5 Zhejiang Kangle Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Paracetamol Value Chain Analysis
- 9.1.1 Paracetamol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Paracetamol Production Mode & Process
- 9.2 Paracetamol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Paracetamol Distributors
- 9.2.3 Paracetamol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst